Edition:
United States

IPCA Laboratories Ltd (IPCA.NS)

IPCA.NS on National Stock Exchange of India

495.55INR
17 Oct 2017
Change (% chg)

Rs-3.75 (-0.75%)
Prev Close
Rs499.30
Open
Rs500.00
Day's High
Rs503.45
Day's Low
Rs493.00
Volume
89,477
Avg. Vol
388,729
52-wk High
Rs657.60
52-wk Low
Rs400.00

Latest Key Developments (Source: Significant Developments)

India's Ipca Laboratories posts June-qtr loss
Friday, 11 Aug 2017 03:59am EDT 

Aug 11 (Reuters) - Ipca Laboratories Ltd ::June quarter loss from continuing operations 202.5 million rupees versus profit of 475.7 million rupees last year.June quarter total income 7.19 billion rupees versus 8.60 billion rupees last year.  Full Article

Ipca Labs says U.S.FDA has not carried new inspections at co's Madhya Pradesh, Pithampur, Silvassa plants
Tuesday, 20 Jun 2017 02:03am EDT 

June 20 (Reuters) - Ipca Laboratories Ltd ::Says clarification on U.S. FDA communication on company's manufacturing units.USFDA clarified issuing letters is for withdrawal of exemption on certain drugs which was due to change in drug shortage situation in us.Says fda has not carried any new inspection/reinspection of its plants at Madhya Pradesh,Pithampur and Silvassa.  Full Article

IPCA Labs says USFDA states drugs from Ratlam facility will be refused admission into U.S.
Thursday, 15 Jun 2017 09:32am EDT 

June 15 (Reuters) - IPCA Laboratories Ltd :Says US FDA update on company's active pharmaceutical ingredients manufacturing facility situated at Ratlam (Madhya Pradesh).Received exchange from USFDA stating drugs manufactured at MP manufacturing facility will be henceforth refused admission into U.S..  Full Article

IPCA Labs says USFDA states drugs from SEZ Indore, Piparia unit will be refused admission into U.S.
Thursday, 15 Jun 2017 09:25am EDT 

June 15 (Reuters) - Ipca Laboratories Ltd ::US FDA update on company's formulations manufacturing units situated at SEZ Indore (Pithampur) and Piparia (Silvassa).Received communication from USFDA stating drugs manufactured at facilities in Indore and Piparia will be refused admission into U.S..  Full Article

Ipca Laboratories June-qtr profit more than doubles
Thursday, 11 Aug 2016 02:36am EDT 

IPCA Laboratories Ltd : June-quarter net profit 475.7 million rupees; net sales INR 8.22 billion . Net profit in June-quarter last year was 209.2 million rupees as per Ind-AS; net sales was 7.49 billion rupees .  Full Article

India's IPCA Laboratories March-qtr profit rises
Monday, 30 May 2016 03:44am EDT 

IPCA Laboratories Ltd : India's IPCA Laboratories Ltd says March-quarter net profit 376.9 million rupees . India's IPCA Laboratories Ltd says March-quarter net sales 6.12 billion rupees versus 6.23 billion rupees year ago .  Full Article

BRIEF-India's Ipca Laboratories posts June-qtr loss

* June quarter loss from continuing operations 202.5 million rupees versus profit of 475.7 million rupees last year